Work

Triepitopic Antibody Fusions Inhibit Cetuximab-Resistant BRAF and KRAS Mutant Tumors via EGFR Signal Repression

Year: 2012

Type: article

Source: Journal of Molecular Biology

DOI: 10.1016/j.jmb.2012.06.014

Authors: Jamie B. Spangler, Mandana T. Manzari, Elizabeth K. Rosalia, Tiffany F. Chen, K. Dane Wittrup

Institutions: Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research At MIT

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Defense Science and Engineering Graduate, National Cancer Institute

Awards: G194228926, Foundations of Pretargeted Radioimmunotherapy, Engineered Antibody EGFR Antagonist Cancer Therapeutics

OpenAlex ID: W1481341612

FWCI:

Cites: 40

Cited by: 1

Related to: 20